On April 28, 2023, Encompass Health (NYSE:EHC) received a Buy rating from Bank of America Securities analyst Kevin Fischbeck, who raised the price target from $69 to $74. This aligns with the consensus among 11 other analysts, who have a median target price of $70.00 for Encompass Health Corp, with a high estimate of $75.00 and a low estimate of $61.00. The majority of the 12 polled investment analysts also suggest buying stock in Encompass Health Corp.
Encompass Health is projected to experience a significant increase in earnings and revenue, with a growth rate of 14.8% and 7.6% per year, respectively. Additionally, the company’s EPS and ROE are expected to grow by 13.9% and 19.1% per year, respectively. Encompass Health has also declared a dividend of $0.15.
As a leading healthcare services company in the United States, Encompass Health provides facility-based and home-based post-acute services through two segments: inpatient rehabilitation and home health and hospice. The company has been expanding its business through strategic partnerships and acquisitions, such as the acquisition of Alacare Home Health & Hospice in 2020 and the joint venture with Landmark Health, a provider of in-home medical care for complex, chronic patients.
Tenet Healthcare Corporation (EHC) Stock Analysis: Strong Rebound with Steady Growth Projections
On April 28, 2023, Tenet Healthcare Corporation (EHC) opened at $64.86 and fluctuated between a low of $63.25 and a high of $65.04, with a volume of 484,359 shares traded. The market cap for EHC was $6.4 billion. EHC experienced a decrease of 34.39% in earnings growth last year, but it has since rebounded with an increase of 7.99% this year. The company is projected to have a steady growth rate of 8.42% over the next five years. The P/E ratio for EHC was 24.7, which is slightly higher than the industry average. The price/sales ratio was 1.38, which is also higher than the industry average. The price/book ratio was 4.86, indicating that the stock may be overvalued. EHC falls under Health Services and Medical/Nursing Services, respectively, and is headquartered in Birmingham, Alabama. EHC’s competitors in the industry, including Surgery Partners Inc, Premier Inc, and Select Medical Holdings Corporation, also experienced slight increases in their stock prices on April 28, 2023. However, EHC had the highest percentage increase, with a gain of 0.65%. The next reporting date for EHC is on July 25, 2023, with an EPS forecast of $0.74. The company had an annual revenue of $4.3 billion and an annual profit of $269.8 million, with a net profit margin of 5.89%. Investors should keep an eye on the company’s revenue growth and valuation ratios to make informed decisions about their investments.
Encompass Health Corps Stock Performance and Future Prospects: A Promising Investment Opportunity in Healthcare Sector
Encompass Health Corp (EHC) is a leading provider of integrated healthcare services, offering inpatient rehabilitation, home health, and hospice services across the United States. The company has been in operation for over 35 years and has built a strong reputation for delivering high-quality care to patients.
On April 28, 2023, EHC’s stock performance was closely watched by investors and analysts alike. According to data from CNN Money, the 11 analysts offering 12-month price forecasts for EHC had a median target of $72.00, with a high estimate of $77.00 and a low estimate of $61.00. This indicates a potential increase of 13.76% from the last price of $63.29.
The current consensus among 12 polled investment analysts is to buy stock in Encompass Health Corp. This rating has held steady since March, when it was unchanged from a buy rating. This indicates that investors are optimistic about the company’s future prospects and are confident in its ability to deliver strong returns.
In terms of financial performance, EHC reported earnings per share of $0.74 and sales of $1.2 billion for the current quarter. These figures reflect a strong performance by the company, indicating that it is well-positioned to continue delivering value to its shareholders.
Overall, EHC’s stock performance on April 28, 2023, was positive, with analysts predicting a potential increase in share price over the next 12 months. Investors are also optimistic about the company’s future prospects, with a consensus rating of buy and strong financial performance in the current quarter. As such, EHC remains a strong investment opportunity for those looking to invest in the healthcare sector.
Source: beststocks.com
